Quick Answer
cbdMD, Inc. reported Total Revenue of $19.19 million for fiscal year 2025.
cbdMD, Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $19.19M -1.5% |
$19.48M -19.3% |
$24.16M -31.8% |
$35.40M -20.4% |
$44.48M +6.2% |
$41.88M +77.1% |
| Net Income | -$2.04M +44.8% |
-$3.70M +83.9% |
-$22.94M +67.3% |
-$70.08M -199.6% |
-$23.39M -285.6% |
$12.60M +124.5% |
| Diluted EPS | — | — | -$13.32 +76.1% |
-$55.80 -11772.3% |
-$0.47 -267.9% |
$0.28 |
| Total Assets | $10.42M -1.5% |
$10.58M -34.7% |
$16.20M -60.3% |
$40.79M -67.3% |
$124.88M +12.7% |
$110.84M +17.3% |
| Cash and Equivalents | $2.26M -7.8% |
$2.45M +36.4% |
$1.80M -73.2% |
$6.72M -74.6% |
$26.41M +78.2% |
$14.82M +216.1% |
| Long-Term Debt | — | — | $9.00 -100.0% |
$125.5K +15.1% |
$109.0K -58.8% |
$264.4K |
| Stockholders Equity | $7.23M +134.1% |
$3.09M -88.0% |
$25.79M -67.8% |
$80.02M -10.4% |
$89.28M | — |
| Operating Income | -$2.16M +34.8% |
-$3.32M +85.3% |
-$22.49M +71.3% |
-$78.27M -299.0% |
-$19.62M -11.6% |
-$17.58M -18.8% |
| Gross Profit | $11.97M -0.2% |
$12.00M -19.9% |
$14.98M -32.9% |
$22.34M -25.5% |
$29.99M +13.7% |
$26.37M +81.7% |
| Shares Outstanding | 8.92M +1711.0% |
492,383 -83.4% |
2.96M +119.6% |
1.35M -97.7% |
57.78M +10.8% |
52.13M +88.1% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | December 31, 2025 | $5.02M | -1.9% | +8.9% |
| Net Income | December 31, 2025 | -$283.1K | -1975.7% | +68.4% |
| Diluted EPS | June 30, 2024 | -$0.15 | +87.1% | +88.9% |
| Total Assets | December 31, 2025 | $11.78M | +2.1% | +13.1% |
| Cash and Equivalents | December 31, 2025 | $3.39M | +72.0% | +49.8% |
| Long-Term Debt | December 31, 2023 | $0.00 | — | -100.0% |
| Stockholders Equity | December 31, 2025 | $9.01M | +405.6% | +24.7% |
| Operating Income | December 31, 2025 | -$286.3K | -231.8% | +68.4% |
| Gross Profit | December 31, 2025 | $3.00M | -11.7% | +6.0% |
| Shares Outstanding | December 31, 2025 | 10.07M | +81.7% | +12.9% |
- cbdMD, Inc. reported Total Revenue of $19.19 million for fiscal year 2025.
- cbdMD, Inc. showed a decrease of -1.5% in Total Revenue compared to the prior fiscal year.
- cbdMD, Inc. reported Net Income of -$2.04 million for fiscal year 2025.
- cbdMD, Inc. showed an increase of +44.8% in Net Income compared to the prior fiscal year.
- cbdMD, Inc. reported Diluted EPS of $13.32 per share (loss) for fiscal year 2023.
- cbdMD, Inc. showed an increase of +76.1% in Diluted EPS compared to the prior fiscal year.
- cbdMD, Inc. reported Total Assets of $10.42 million for fiscal year 2025.
- cbdMD, Inc. showed a decrease of -1.5% in Total Assets compared to the prior fiscal year.
- cbdMD, Inc. reported Cash and Equivalents of $2.26 million for fiscal year 2025.
- cbdMD, Inc. showed a decrease of -7.8% in Cash and Equivalents compared to the prior fiscal year.
- cbdMD, Inc. reported Long-Term Debt of $9.00 for fiscal year 2023.
- cbdMD, Inc. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- cbdMD, Inc. reported Stockholders Equity of $7.23 million for fiscal year 2025.
- cbdMD, Inc. showed an increase of +268.0% in Stockholders Equity compared to the prior fiscal year.
- cbdMD, Inc. reported Operating Income of -$2.16 million for fiscal year 2025.
- cbdMD, Inc. showed an increase of +34.8% in Operating Income compared to the prior fiscal year.
- cbdMD, Inc. reported Gross Profit of $11.97 million for fiscal year 2025.
- cbdMD, Inc. showed a decrease of -0.2% in Gross Profit compared to the prior fiscal year.
- cbdMD, Inc. reported Shares Outstanding of 8.92 million shares for fiscal year 2025.
- cbdMD, Inc. showed an increase of +1711.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: